11Nov
COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)
In Tuesday's Report: the expanding role of real-world evidence in FDA medical device submissions; President-elect Joe Biden lays out COVID-19 plan; Pfizer announces vaccine efficacy; and an analysis of material adverse change (MAC) clauses in Japan....
By:
Hogan Lovells
Source Url: https://www.jdsupra.com/legalnews/covid-19-report-for-life-sciences-and-24214/
Related
The 2020-2021 Ohio Biennial Budget has passed, and one important aspect for businesses is the statut...
Read More >
Earlier this summer the New York State Senate and Assembly passed a bill aimed to amend the New York...
Read More >
Yesterday, a group of workers at some of the travel plazas in Connecticut, along with members of Loc...
Read More >
Massachusetts employers should be making their final preparations for the Massachusetts Paid Family ...
Read More >
A federal court in Manhattan has invalidated New York's statewide prohibition against provisions in ...
Read More >
October 1 is the deadline for broadcast stations licensed to communities in Alaska, American Samoa, ...
Read More >